Association Between Metastatic Patterns and Overall Survival in Metastatic Gastric Cancer: A Single-Centre Real-World Study
Objective: Metastatic gastric cancer is a biologically heterogeneous disease with a poor prognosis. Although the presence of distant metastasis defines advanced disease, the prognostic impact of specific metastatic patterns remains unclear. This study aimed to evaluate the association between metastatic patterns and overall survival in patients with metastatic gastric cancer.
Methods: In this retrospective single-centre study, 292 patients with histopathologically confirmed metastatic gastric cancer were included. Metastatic sites were evaluated using computed tomography, magnetic resonance imaging, and/or positron emission tomography. Overall survival (OS) was analysed using the Kaplan–Meier method and compared using the log-rank test. Prognostic factors were assessed through univariate and multivariate Cox proportional hazards regression models.
Results: The median OS for the entire cohort was 10 months (95% CI, 9.3–12.0). The most common sites of metastasis were non-regional lymph nodes (78.8%), liver (49.7%), and peritoneum (30.8%). Peritoneal metastasis was associated with significantly worse survival in unadjusted Kaplan–Meier analysis (9.5 vs 11 months, P<0.001), whereas other metastatic sites were not significantly associated with OS. No significant difference in OS was observed between patients with single-site and multiple-site metastases (P=0.31). In multivariate analysis, Eastern Cooperative Oncology Group performance status (ECOG) and prior gastrectomy were identified as independent prognostic factors, while the impact of metastatic site did not remain statistically significant.
Conclusion: Metastatic gastric cancer exhibits substantial heterogeneity in survival outcomes according to the distribution of metastatic sites. Peritoneal involvement was associated with worse survival in unadjusted analyses and may represent a clinically relevant marker of adverse prognosis. Including site-specific metastatic information in prognostic assessments may contribute to improved risk stratification in addition to the conventional staging system.
1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. doi: 10.3322/caac.21834.
2. Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57. doi: 10.1186/s13045-023-01451-3.
3. Park JY, Georges D, Alberts CJ, Bray F, Clifford G, Baussano I. Global lifetime estimates of expected and preventable gastric cancers across 185 countries. Nat Med. 2025;31(9):3020-3027. doi: 10.1038/s41591-025-03793-6.
4. Hsu JT, Lin YN, Chen YF, et al. A comprehensive overview of gastric cancer management from a surgical point of view. Biomed J. 2025;48(4):100817. doi: 10.1016/j.bj.2024.100817.
5. Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9(3):215-221. doi: 10.1016/S1470-2045(08)70035-4.
6. Desiderio J, Sagnotta A, Terrenato I, et al. Gastrectomy for stage IV gastric cancer: a comparison of different treatment strategies from the SEER database. Sci Rep. 2021;11(1):7150. doi: 10.1038/s41598-021-86352-6.
7. Zhang Y, Lin Y, Duan J, Xu K, Mao M, Wang X. A Population-Based Analysis of Distant Metastasis in Stage IV Gastric Cancer. Med Sci Monit. 2020;26:e923867. doi: 10.12659/MSM.923867.
8. In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T. Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database. Ann Surg Oncol. 2017;24(12):3683-3691. doi: 10.1245/s10434-017-6078-x.
9. Alshehri A, Alanezi H, Kim BS. Prognosis factors of advanced gastric cancer according to sex and age. World J Clin Cases. 2020;8(9):1608-1619. doi: 10.12998/wjcc.v8.i9.1608.
10. Feng Y, Guo K, Jin H, Xiang Y, Zhang Y, Ruan S. A Predictive Nomogram for Early Mortality in Stage IV Gastric Cancer. Med Sci Monit. 2020;26:e923931. doi: 10.12659/MSM.923931.
11. Zhan PL, Canavan ME, Ermer T, et al. Association Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer: Potential for Stage Classification Reform. Ann Surg Oncol. 2023;30(7):4180-4191. doi: 10.1245/s10434-023-13287-9.
12. Sirody J, Kaji AH, Hari DM, Chen KT. Patterns of gastric cancer metastasis in the United States. Am J Surg. 2022;224(1 Pt B):445-448. doi: 10.1016/j.amjsurg.2022.01.024.
13. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. doi: 10.3322/caac.21820.
14. Mülder DT, Hahn AI, Huang RJ, et al. Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2024;22(8):1605-1617.e46. doi: 10.1016/j.cgh.2024.02.023.
15. Huang X, Li Z, Weng Q. Clinicopathological features and prognostic significance of site-specific metastasis in gastric cancer: a population-based, propensity score-matched analysis. Discov Oncol. 2025;16(1):1164. doi: 10.1007/s12672-025-02865-w.
16. López MJ, Carbajal J, Alfaro AL, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2023;181:103841. doi: 10.1016/j.critrevonc.2022.103841.
17. Yang H, Ji K, Ji J. Current status and perspectives of conversion therapy for advanced gastric cancer. Chin J Cancer Res. 2022;34(2):109-114. doi: 10.21147/j.issn.1000-9604.2022.02.05.
18. Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget. 2016;7(32):52307-52316. doi: 10.18632/oncotarget.10740.
19. Jo JC, Ryu MH, Koo DH, et al. Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer. Asia Pac J Clin Oncol. 2013;9(4):324-330. doi: 10.1111/ajco.12019.
20. Rijken A, Lurvink RJ, Luyer MDP, et al. The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival. J Clin Med. 2021;10(21):4882. doi: 10.3390/jcm10214882.
21. Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93-99. doi: 10.3322/caac.21388.
22. Kong X, Wang JL, Chen HM, Fang JY. Comparison of the clinicopathological characteristics of young and elderly patients with gastric carcinoma: a meta analysis. J Surg Oncol. 2012;106(3):346-352. doi: 10.1002/jso.23004.
23. Tan HL, Chia CS, Tan GHC, et al. Metastatic gastric cancer: Does the site of metastasis make a difference? Asia Pac J Clin Oncol. 2019;15(1):10-17. doi: 10.1111/ajco.13025.
24. Luo S, Wang H, Tang R, et al. BUB1-based risk model predicts prostate cancer prognosis and reveals therapeutic vulnerabilities. Eur J Med Res. 2025;30(1):812. doi: 10.1186/s40001-025-03098-x.
25. Takahari D, Mizusawa J, Koizumi W, Hyodo I, Boku N. Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials. Gastric Cancer. 2017;20(5):757-763. doi: 10.1007/s10120-017-0702-0.
26. Chau I, Norman AR, Cunningham D, Waters JS, Oates J, Ross PJ. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol. 2004;22(12):2395-2403. doi: 10.1200/JCO.2004.08.154.
27. Müsri FY, Mutlu H, Karaağaç M, Eryilmaz MK, Gündüz Ş, Artaç M. Primary Tumor Resection and Survival in Patients with Stage IV Gastric Cancer. J Gastric Cancer. 2016;16(2):78-84. doi: 10.5230/jgc.2016.16.2.78.
28. Warschkow R, Baechtold M, Leung K, et al. Selective survival advantage associated with primary tumor resection for metastatic gastric cancer in a Western population. Gastric Cancer. 2018;21(2):324-337. doi: 10.1007/s10120-017-0742-5.
Copyright (c) 2026 The European Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Article Information
- Article Type Research Article
- Submitted May 4, 2026
- Accepted June 28, 2026
- Published August 1, 2026
- Issue Forthcoming Issue: Volume 12 - Issue 8 (August 2026)
- Section Research Article
- Categories
The data that support the findings of this study are available from the corresponding author upon reasonable request.
